<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H368465F2F2CD498ABC0CC680F0971860" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>113 HR 1188 IH: Preserving Our Hometown Independent Pharmacies Act of 2013</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2013-03-14</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>H. R. 1188</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20130314">March 14, 2013</action-date>
			<action-desc><sponsor name-id="M001179">Mr. Marino</sponsor> (for
			 himself and <cosponsor name-id="C001080">Ms. Chu</cosponsor>) introduced the
			 following bill; which was referred to the <committee-name committee-id="HJU00">Committee on the Judiciary</committee-name></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To ensure and foster continued safety and quality of care
		  and a competitive marketplace by exempting independent pharmacies from the
		  antitrust laws in their negotiations with health plans and health insurance
		  insurers.</official-title>
	</form>
	<legis-body id="H6572E98762974B908E7184F803FF89A1" style="OLC">
		<section display-inline="no-display-inline" id="H575858B1DD8D4854AFFC22A3CACE8FCF" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the
			 <quote><short-title>Preserving Our Hometown Independent
			 Pharmacies Act of 2013</short-title></quote>.</text>
		</section><section id="H33880D8DB88D4512873EFF43EBCB4F8C"><enum>2.</enum><header>Application of
			 the antitrust laws to independent pharmacies negotiating with health
			 plans</header>
			<subsection id="HE977D3F4539348BFAB967F35A311E622"><enum>(a)</enum><header>In
			 general</header><text display-inline="yes-display-inline">Any independent
			 pharmacies who are engaged in negotiations with a health plan regarding the
			 terms of any contract under which the pharmacies provide health care items or
			 services for which benefits are provided under such plan shall, only in
			 connection with such negotiations, be treated under the antitrust laws as an
			 employee engaged in concerted activities and shall not be regarded as having
			 the status of an employer, independent contractor, managerial employee, or
			 supervisor.</text>
			</subsection><subsection id="HCA7C9B9199584F2EB0D6045E424477F2"><enum>(b)</enum><header>Protection for
			 good faith actions</header><text>Actions taken in good faith reliance on
			 subsection (a) shall not be the subject under the antitrust laws of criminal
			 sanctions nor of any civil damages, fees, or penalties beyond actual damages
			 incurred.</text>
			</subsection><subsection id="H54E67409925E458C86CA1521100442E4"><enum>(c)</enum><header>No change in
			 National Labor Relations Act</header><text>Nothing in this section shall be
			 construed as changing or amending any provision of the National Labor Relations
			 Act, or as affecting the status of any group of persons under that Act.</text>
			</subsection><subsection id="H8F76E480A54649E9B3B5547FB133AA43"><enum>(d)</enum><header>Effective
			 date</header><text>The exemption provided in subsection (a) shall apply to
			 conduct occurring beginning on the date of the enactment of this Act.</text>
			</subsection><subsection id="H0C4A2D7F7A6A4278BB16708D297B2474"><enum>(e)</enum><header>Limitations on
			 exemption</header><text>Nothing in this section shall exempt from the
			 application of the antitrust laws any agreement or otherwise unlawful
			 conspiracy that—</text>
				<paragraph id="H589CD15F111C41C2B17296E1B01F4801"><enum>(1)</enum><text display-inline="yes-display-inline">would have the effect of boycotting any
			 independent pharmacy or group of independent pharmacies, or would exclude,
			 limit the participation or reimbursement of, or otherwise limit the scope of
			 services to be provided by, any independent pharmacy or group of independent
			 pharmacies with respect to the performance of services that are within the
			 scope of practice as defined or permitted by relevant law or regulation;</text>
				</paragraph><paragraph id="H0BDF7C859ED64775B8319018A88CECCE"><enum>(2)</enum><text display-inline="yes-display-inline">allocates a market among
			 competitors;</text>
				</paragraph><paragraph id="H8FD975DCBD564B2ABA122F01B937CC8C"><enum>(3)</enum><text>unlawfully ties
			 the sale or purchase of one product or service to the sale or purchase of
			 another product or service; or</text>
				</paragraph><paragraph id="HE8CA3719099D4694BA8FDCC0C62920EA"><enum>(4)</enum><text>monopolizes or
			 attempts to monopolize a market.</text>
				</paragraph></subsection><subsection display-inline="no-display-inline" id="H7E6907811F55447D9042BD65159541D7"><enum>(f)</enum><header>Limitation based
			 on market share of group</header><text>This section shall not apply with
			 respect to the negotiations of any group of independent pharmacies with a
			 health plan regarding the terms of any contract under which such pharmacies
			 provide health care items or services for which benefits are provided under
			 such plan in a PDP region (as defined in subsection (j)(4)) if the number of
			 pharmacy licenses of such pharmacies within such group in such region exceeds
			 25 percent of the total number of pharmacy licenses issued to all retail
			 pharmacies (including both independent and other pharmacies) in such
			 region.</text>
			</subsection><subsection id="H01523B256A294656A9433D92F6918155"><enum>(g)</enum><header>No effect on
			 title VI of <act-name parsable-cite="CRA64">Civil Rights Act of
			 1964</act-name></header><text>Nothing in this section shall be construed to
			 affect the application of title VI of the <act-name parsable-cite="CRA64">Civil
			 Rights Act of 1964</act-name>.</text>
			</subsection><subsection id="HF828C9CCCCCB4613AFF1501A5E14C025"><enum>(h)</enum><header>No application
			 to specified Federal programs</header><text>Nothing in this section shall apply
			 to negotiations between independent pharmacies and health plans pertaining to
			 benefits provided under any of the following:</text>
				<paragraph id="H22EC1D1DC2B5494094B15EB45CF975D4"><enum>(1)</enum><text>The Medicaid
			 Program under title XIX of the <act-name parsable-cite="SSA">Social Security
			 Act</act-name> (<external-xref legal-doc="usc" parsable-cite="usc/42/1396">42 U.S.C. 1396 et seq.</external-xref>).</text>
				</paragraph><paragraph id="HD8B8261531EB428EB5A48A6F15D894E4"><enum>(2)</enum><text>The State
			 Children’s Health Insurance Program (SHIP) under title XXI of the
			 <act-name parsable-cite="SSA">Social Security Act</act-name> (42 U.S.C. 1397aa
			 et seq.).</text>
				</paragraph><paragraph id="H216C66143B0845F0B016DA00EE126948"><enum>(3)</enum><text>Chapter 55 of
			 title 10, United States Code (relating to medical and dental care for members
			 of the uniformed services).</text>
				</paragraph><paragraph id="HEC53791FDEA14B2586DF556603645A65"><enum>(4)</enum><text>Chapter 17 of
			 title 38, United States Code (relating to Veterans’ medical care).</text>
				</paragraph><paragraph id="H956A68C8518D4EC3B4060ABBEEA87C37"><enum>(5)</enum><text>Chapter 89 of
			 title 5, United States Code (relating to the Federal employees’ health benefits
			 program).</text>
				</paragraph><paragraph id="H9CA8AAD4A4EC461EBE633F818721F291"><enum>(6)</enum><text>The
			 <act-name parsable-cite="IHCIA">Indian Health Care Improvement Act</act-name>
			 (<external-xref legal-doc="usc" parsable-cite="usc/25/1601">25 U.S.C. 1601 et seq.</external-xref>).</text>
				</paragraph><paragraph id="HB1F8D6C3109A45D7B1B19E217B54CC45"><enum>(7)</enum><text>Part C or D of
			 title XVIII of the Social Security Act.</text>
				</paragraph></subsection><subsection id="H12591E34004746AC90562689089C02FF"><enum>(i)</enum><header>Definitions</header><text>For
			 purposes of this section:</text>
				<paragraph id="H9549DE5AA30E4AFD94A53A355A040BE7"><enum>(1)</enum><header>Antitrust
			 laws</header><text>The term <term>antitrust laws</term>—</text>
					<subparagraph id="H7A2139522E5E43FDA282EB5A5E108B39"><enum>(A)</enum><text>has the meaning
			 given it in subsection (a) of the first section of the
			 <act-name parsable-cite="CLAY">Clayton Act</act-name> (<external-xref legal-doc="usc" parsable-cite="usc/15/12">15 U.S.C. 12(a)</external-xref>), except
			 that such term includes section 5 of the <act-name parsable-cite="FTCA">Federal
			 Trade Commission Act</act-name> (<external-xref legal-doc="usc" parsable-cite="usc/15/45">15 U.S.C. 45</external-xref>) to the extent such section 5
			 applies to unfair methods of competition; and</text>
					</subparagraph><subparagraph id="H1C8DCCACE2A346699D9627442113CB15"><enum>(B)</enum><text>includes any State
			 law similar to the laws referred to in subparagraph (A).</text>
					</subparagraph></paragraph><paragraph id="H19A1252F3D6F40BD886DC10C55F83CCD"><enum>(2)</enum><header>Health plan and
			 related terms</header>
					<subparagraph id="H3A7DF549C43A4DADB0F17C2BC037A370"><enum>(A)</enum><header>In
			 general</header><text display-inline="yes-display-inline">The term <term>health
			 plan</term>—</text>
						<clause id="HEEE5859C39E949488F44B7785E1AB69C"><enum>(i)</enum><text>means a group
			 health plan or a health insurance issuer that is offering health insurance
			 coverage;</text>
						</clause><clause id="HCD05B7536511481CBE1E0F59B51C5F20"><enum>(ii)</enum><text>includes any
			 entity that contracts with such a plan or issuer for the administering of
			 services under the plan or coverage; and</text>
						</clause><clause id="H49F80538D8D14532B94851893B217220"><enum>(iii)</enum><text>does not include
			 a Medicare Advantage plan offered under part C of title XVIII of the Social
			 Security Act or a prescription drug plan offered under part D of such
			 title.</text>
						</clause></subparagraph><subparagraph id="H2986ED7C094947E7A85749A6EB75705A"><enum>(B)</enum><header>Health insurance
			 coverage; health insurance issuer</header><text>The terms <term>health
			 insurance coverage</term> and <term>health insurance issuer</term> have the
			 meanings given such terms under paragraphs (1) and (2), respectively, of
			 section 733(b) of the <act-name parsable-cite="ERISA">Employee Retirement
			 Income Security Act of 1974</act-name> (<external-xref legal-doc="usc" parsable-cite="usc/29/1191b">29 U.S.C. 1191b(b)</external-xref>).</text>
					</subparagraph><subparagraph id="HEF229D4793294F9CA0F9057AABD69EAC"><enum>(C)</enum><header>Group health
			 plan</header><text>The term <term>group health plan</term> has the meaning
			 given that term in section 733(a)(1) of the <act-name parsable-cite="ERISA">Employee Retirement Income Security Act of
			 1974</act-name> (<external-xref legal-doc="usc" parsable-cite="usc/29/1191b">29 U.S.C. 1191b(a)(1)</external-xref>).</text>
					</subparagraph></paragraph><paragraph id="H24AD2626607941018BD87F9C34A0C2DC"><enum>(3)</enum><header>Independent
			 pharmacy</header><text display-inline="yes-display-inline">The term
			 <term>independent pharmacy</term> means a pharmacy that has a market share
			 of—</text>
					<subparagraph id="H4D6A2827291046C1BB9262ECD3E7B8F3"><enum>(A)</enum><text>less than 10
			 percent in any PDP region; and</text>
					</subparagraph><subparagraph id="H4A6157667A94465F941D18D9866F7944"><enum>(B)</enum><text>less than 1
			 percent in the United States.</text>
					</subparagraph><continuation-text continuation-text-level="paragraph">For purposes
			 of the preceding sentence, all pharmacies that are members of the same
			 controlled group of corporations (within the meaning of section 267(f) of the
			 Internal Revenue Code of 1986) and all pharmacies under common control (within
			 the meaning of section 52(b) of such Code but determined by treating an
			 interest of more than 50 percent as a controlling interest) shall be treated as
			 1 pharmacy.</continuation-text></paragraph><paragraph id="H44D92E7B24494C7EB6A3DB35EE77EE4D"><enum>(4)</enum><header>PDP
			 region</header><text display-inline="yes-display-inline">The term <term>PDP
			 region</term> has the meaning given such term in section 1860D–11(a)(2) of the
			 Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-111">42 U.S.C. 1395w–111(a)(2)</external-xref>).</text>
				</paragraph></subsection><subsection id="H849D55539DE442EC96A16089CB8C238A"><enum>(j)</enum><header>5-Year
			 sunset</header><text display-inline="yes-display-inline">The exemption provided
			 in subsection (a) shall only apply to conduct occurring during the 5-year
			 period beginning on the date of the enactment of this Act and shall continue to
			 apply for 1 year after the end of such period to contracts entered into before
			 the end of such period.</text>
			</subsection><subsection id="HDC3EA1C4D6794E3BA2C3458820D27E65"><enum>(k)</enum><header>General
			 accountability office study and report</header><text display-inline="yes-display-inline">The Comptroller General of the United
			 States shall conduct a study on the impact of enactment of this section during
			 the 6-month period beginning with the 5th year of the 5-year period described
			 in subsection (j). Not later than the end of such 6-month period, the
			 Comptroller General shall submit to Congress a report on such study and shall
			 include in the report such recommendations on the extension of this section
			 (and changes that should be made in making such extension) as the Comptroller
			 General deems appropriate.</text>
			</subsection><subsection id="H4147DA1AEF9246449220AC4D444027D9"><enum>(l)</enum><header>Oversight</header><text>Nothing
			 in this section shall preclude the Federal Trade Commission or the Department
			 of Justice from overseeing the conduct of independent pharmacies covered under
			 this section.</text>
			</subsection></section></legis-body>
</bill>


